Hiroyasu Toyota

This inventor holds 4 USPTO granted patents and 9 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Astellas Pharma Gmbh, Medivation Prostate Therapeutics, Inc., Ambit Biosciences Corporation. Active years: 2017-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hiroyasu Toyota. Retrieved from https://idiyas.com/inventor/hiroyasu-toyota

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 (Patent Applications = 9)

% Patents Active = 100.0

CIPO Patents = 1

EPO Patents = 3 (Patent Applications = 6)

Average Co-Inventor Count = 9.6

ph-index = 1

Forward Citations = 3(Granted Patents)

Location History:

Chuo-ku Tokyo, JP (2017)
Tokyo, JP (2023)

Company Filing History:

Medivation Prostate Therapeutics, Inc.

patents

1 out of 39

Ambit Biosciences Corporation

patents

where one patent can have more than one assignee

Years Active: 2017-2025

Loading Chart...

4 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12502357 - Formulations of enzalutamide (2025-12-23),

2. 12447128 - Formulations of enzalutamide (2025-10-21),

3. 11839689 - Formulations of enzalutamide (2023-12-12),

4. 9675549 - Tablet containing composite with cyclodextrin (2017-06-13),

Title: Hiroyasu Toyota: Innovator in Pharmaceutical Formulations

Introduction

Hiroyasu Toyota is a notable inventor based in Japan, recognized for his contributions to pharmaceutical formulations. His work primarily focuses on the development of innovative treatments for hyperproliferative disorders.

Latest Patents

Hiroyasu Toyota holds a patent related to the formulations of enzalutamide. This patent describes a formulation of a solid dispersion containing amorphous enzalutamide and hydroxypropyl methylcellulose acetate succinate, highlighting its use in treating hyperproliferative disorders.

Career Highlights

Throughout his career, Hiroyasu Toyota has made significant strides in the pharmaceutical industry. He has been involved in research and development that aims to improve treatment options for patients suffering from various conditions.

Collaborations

Hiroyasu Toyota has collaborated with prominent companies in the pharmaceutical sector, including Astellas Pharma GmbH and Medivation Prostate Therapeutics, Inc. These partnerships have allowed him to leverage resources and expertise to advance his innovative work.

Conclusion

Hiroyasu Toyota's contributions to pharmaceutical formulations demonstrate his commitment to improving healthcare through innovation. His work continues to impact the field positively, paving the way for new treatment options.

Profile summary based on public USPTO records.